Abnova公司是哪个国家的

Abnova公司简介 Abnova是世界上最大的单克隆抗体生产商之一，现有抗体产品种类近30000种，其中2/3是单克隆抗体。和传统的单克隆抗体生产方法相比，Abnova采用更先进的技术和设备，可以极大地提高单克隆抗体的生产效率并降低其生产的成本。Abnova具有每个月开发500个小鼠单克隆抗体的能力，他们的目标是：人类基因组中的每一个表达基因都至少有一种抗体。 The Gap between Genomics and Proteomics After the completion of human genomic project, most human expressed genes have been identified, and full-length cDNA of these genes have become publicly available. In the emerging proteomics era, proteins act as the key players in the unveiling of these genes. In order to effectively decipher the mystery of these proteins, antibodies with their inherent sensitivity and specificity thus become the most versatile tools for providing one-to-one relationship with their target proteins. What Abnova Does The mission of Abnova is to become a leader in high throughput antibody and protein production. Abnova intends to become worlds largest protein and antibody catalog company by building a full collection of essential proteins and their antibodies targeting the human genome. Why Choose Abnova? Abnova offers a unique complete monoclonal antibody and protein experience for our customer that is different from traditional custom production companies and laboratories. Industrial-Scale Infrastructure: We maintain a streamlined monoclonal production facility with scalable capacity for up to 500 immunization per month, and a state-of-the-art specific pathogen free (SPF) facility, which has the breeding and holding capacity for 10,000+ mice. These facilities allow us to significantly bring down the cost of customized monoclonal antibody production. We have also incorporated numerous automation systems into our production line, which significantly increased our efficiency. Wheat Germ In Vitro Protein Expression System: We have a high throughput protein production system, which allows soluble expression of conformational correct protein either from full-length cDNA or specific domains.